Who Is Bryan Hubbard? CEO of Americans for Ibogaine
His work has focused on proposals to develop ibogaine as a treatment for addiction.
Bryan Hubbard is CEO of Americans for Ibogaine. Business Insider
At Mind Medicine Law, we track the people building legal, evidence-based access to psychedelic medicine: the companies running the trials, the researchers and advocates behind them, and the officials who write and run the laws.
Hubbard chaired Kentucky’s Opioid Abatement Commission starting in 2022, proposed setting aside $42 million in opioid settlement funds for ibogaine development, and helped move the initiative from Kentucky to Texas. WCPO
Where Bryan Hubbard Is Now
- Current role: CEO. Business Insider
- Organization: Americans for Ibogaine. Business Insider
- Known for: Proposing that Kentucky set aside $42 million in opioid settlement funds to develop ibogaine as a treatment. WCPO
- Recent news: He was in the Oval Office when President Donald Trump signed an executive order encouraging ibogaine research on April 18, 2026. The Hindu
W. Bryan Hubbard is CEO of Americans for Ibogaine. Business Insider
Work in Kentucky and Texas
Hubbard chaired Kentucky’s Opioid Abatement Commission starting in 2022. He proposed setting aside $42 million in Kentucky opioid settlement funds to develop ibogaine as a treatment. WCPO
The Kentucky funding proposal was blocked after a change in gubernatorial administration. Hubbard helped move the ibogaine development initiative from Kentucky to Texas. WCPO
April 2026 News
Hubbard was in the Oval Office when Trump signed an executive order encouraging ibogaine research on April 18, 2026. The Hindu
Hubbard said a movement to bring ibogaine into the U.S. healthcare system had prompted action at the highest levels of the federal government. The White House
Goals and Statements on Safety
Hubbard aims to secure FDA approval of ibogaine within six years. He wants treatment infrastructure that is accessible in both availability and affordability, and is working to secure ibogaine-related legislative commitments from 12 states in addition to Texas. WCPO
Hubbard has said ibogaine carries serious cardiac risks and requires medical supervision. He has described treatment as typically involving 10 to 12 hours of continuous medical monitoring followed by an extended recovery period. WCPO Just the News
Frequently asked questions
Who is Bryan Hubbard?
W. Bryan Hubbard is CEO of Americans for Ibogaine. Business Insider
What was Bryan Hubbard’s role in Kentucky?
He chaired Kentucky’s Opioid Abatement Commission starting in 2022. WCPO
What funding did Bryan Hubbard propose?
He proposed setting aside $42 million in Kentucky opioid settlement funds to develop ibogaine as a treatment. The proposal was blocked after a change in gubernatorial administration. WCPO
Did Bryan Hubbard work on an ibogaine initiative in Texas?
He helped move the ibogaine development initiative from Kentucky to Texas. WCPO
Was Bryan Hubbard present when Trump signed an ibogaine research order?
He was in the Oval Office when Trump signed an executive order encouraging ibogaine research on April 18, 2026. The Hindu
What has Bryan Hubbard said about ibogaine’s risks?
He has said ibogaine carries serious cardiac risks and requires medical supervision. WCPO
Sources
General information compiled from the public reporting cited above, not medical or legal advice. Mention of a treatment, trial or bill is not a claim that it is safe, effective or legal where you live. Not endorsed by or affiliated with Bryan Hubbard or Americans for Ibogaine. See more people in psychedelic medicine.